{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:56:35Z","timestamp":1746320195364},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40744-020-00210-x","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T04:02:51Z","timestamp":1588392171000},"page":"401-413","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases"],"prefix":"10.1007","volume":"7","author":[{"given":"Hermine","family":"Leroi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Badot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieke","family":"Devinck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Geusens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Kleimberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Swinnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Roggeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,2]]},"reference":[{"key":"210_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cyto.2016.07.015","volume":"86","author":"C Thompson","year":"2016","unstructured":"Thompson C, Davies R, Choy E. Anti-cytokine therapy in chronic inflammatory arthritis. Cytokine. 2016;86:92\u20139.","journal-title":"Cytokine"},{"key":"210_CR2","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.clinthera.2010.09.003","volume":"32","author":"EG Boyce","year":"2010","unstructured":"Boyce EG, Halilovic J, Stan-Ugbene O. Golimumab: review of the efficacy and tolerability of a recently approved tumor necrosis factor-alpha inhibitor. Clin Ther. 2010;32:1681\u2013703.","journal-title":"Clin Ther"},{"key":"210_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/ard.2008.099010","volume":"68","author":"EC Keystone","year":"2009","unstructured":"Keystone EC, Genovese MC, Klareskog L, Hsia EC, Hall ST, Miranda PC, Pazdur J, Bae SC, Palmer W, Zrubek J, et al. Golimumab, a human antibody to tumour necrosis factor alpha given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis. 2009;68:789\u201396.","journal-title":"Ann Rheum Dis"},{"key":"210_CR4","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1002\/art.23969","volume":"58","author":"RD Inman","year":"2008","unstructured":"Inman RD, Davis JC Jr, Heijde D, Diekman L, Sieper J, Kim SI, Mack M, Han J, Visvanathan S, Xu Z, et al. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheumatol. 2008;58:3402\u201312.","journal-title":"Arthritis Rheumatol"},{"key":"210_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/art.24403","volume":"60","author":"A Kavanaugh","year":"2009","unstructured":"Kavanaugh A, McInnes I, Mease P, Krueger GG, Gladman D, Gomez-Reino J, Papp K, Zrubek J, Mudivarthy S, Mack M, et al. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheumatol. 2009;60:976\u201386.","journal-title":"Arthritis Rheumatol"},{"key":"210_CR6","doi-asserted-by":"publisher","first-page":"e021082","DOI":"10.1136\/bmjopen-2017-021082","volume":"8","author":"K Kruger","year":"2018","unstructured":"Kruger K, Burmester GR, Wassenberg S, Bohl-Buhler M, Thomas MH. Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany. BMJ Open. 2018;8:e021082.","journal-title":"BMJ Open"},{"key":"210_CR7","first-page":"141","volume":"42","author":"AF Mourao","year":"2017","unstructured":"Mourao AF, Ribeiro C, Borges J, Goncalves MJ, Bernardes M, Fernandes S, Dezerto R, Laires P, Machado P, Eusebio M, et al. Real-life effectiveness of Golimumab in biologic-naive patients with rheumatoid arthritis\u2014data from the Rheumatic Diseases Portuguese Register (Reuma.pt). Acta Reumatol Port. 2017;42:141\u20139.","journal-title":"Acta Reumatol Port"},{"key":"210_CR8","doi-asserted-by":"crossref","unstructured":"Rotar Z, Tomsic M, Praprotnik S (2018) The persistence of golimumab compared to other tumour necrosis factor-alpha inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs-BioRx.si. Clin Rheumatol.","DOI":"10.1007\/s10067-018-4324-7"},{"key":"210_CR9","first-page":"254","volume":"36","author":"K Thomas","year":"2018","unstructured":"Thomas K, Flouri I, Repa A, Fragiadaki K, Sfikakis PP, Koutsianas C, Kaltsonoudis E, Voulgari PV, Drosos AA, Petrikkou E, et al. High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real-world data from 328 patients. Clin Exp Rheumatol. 2018;36:254\u201362.","journal-title":"Clin Exp Rheumatol"},{"key":"210_CR10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.reuma.2017.02.004","volume":"14","author":"R Almodovar","year":"2017","unstructured":"Almodovar R, Gratacos J, Zarco P. Information needs of patients with spondyloarthritis about their disease. Reumatol Clin. 2017;14:367\u201371.","journal-title":"Reumatol Clin"},{"key":"210_CR11","doi-asserted-by":"publisher","DOI":"10.3402\/qhw.v5i2.5146","author":"I Larsson","year":"2010","unstructured":"Larsson I, Bergman S, Fridlund B, Arvidsson B. Patients\u2019 independence of a nurse for the administration of subcutaneous anti-TNF therapy: a phenomenographic study. Int J Qual Stud Health Well-being. 2010. https:\/\/doi.org\/10.3402\/qhw.v5i2.5146.","journal-title":"Int J Qual Stud Health Well-being"},{"key":"210_CR12","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.ijnurstu.2015.05.008","volume":"52","author":"RM Zuidema","year":"2015","unstructured":"Zuidema RM, Repping-Wuts H, Evers AW, van Gaal BG, Van Achterberg T. What do we know about rheumatoid arthritis patients\u2019 support needs for self-management? A scoping review. Int J Nurs Stud. 2015;52:1617\u201324.","journal-title":"Int J Nurs Stud"},{"key":"210_CR13","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s10067-017-3642-5","volume":"36","author":"J Packham","year":"2017","unstructured":"Packham J, Arkell P, Sheeran T, Brownfield A, Cadwgan A, Ryan S. Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication: a quantitative study. Clin Rheumatol. 2017;36:2595\u2013600.","journal-title":"Clin Rheumatol"},{"key":"210_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.2047-3095.2013.01231.x","volume":"24","author":"JED Cottrell","year":"2013","unstructured":"Cottrell JED, Jonas M, Bergsten U, Blaas E, de la Torre AJ, Howse C, Korandova J, Lofman P, Logtenberg C, Lupton T, et al. The nurse\u2019s role in addressing unmet treatment and management needs of patients with rheumatoid arthritis: Delphi-based recommendations. Int J Nurs Knowl. 2013;24:66\u201376.","journal-title":"Int J Nurs Knowl"},{"key":"210_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3899\/jrheum.160535","volume":"44","author":"S Garner","year":"2017","unstructured":"Garner S, Lopatina E, Rankin JA, Marshall DA. Nurse-led care for patients with rheumatoid arthritis: a systematic review of the effect on quality of care. J Rheumatol. 2017;44:757\u201365.","journal-title":"J Rheumatol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-020-00210-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T09:02:46Z","timestamp":1714726966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-020-00210-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["210"],"URL":"https:\/\/doi.org\/10.1007\/s40744-020-00210-x","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,2]]},"assertion":[{"value":"13 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}